Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple vs Dual Antiplatelet Therapy After ZES for Long Coronary Lesions (DECLARE-LONG)
NCT00589927Phase 4Completed
- Sponsor
- Cardiovascular Research Foundation
- Start
- Dec 2007
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in coronary artery disease (CAD), sponsored by Cardiovascular Research Foundation. Started Dec 2007; status: completed.
02
Drugs
cilostazol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00589927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589927.